Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 5.0B | 4.8B | 4.5B | 4.1B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 1.4B | 1.5B | 1.4B | 1.4B |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 2.4B | 2.1B | 2.0B | 1.6B |
| Tax provision | 577.0M | 465.4M | 396.3M | 369.9M |
| Net income | 1.8B | 1.6B | 1.6B | 1.2B |
| Basic EPS | 1.1 | 1.0 | 0.9 | 0.7 |
| Diluted EPS | 1.1 | 1.0 | 0.9 | 0.7 |
| Basic average shares | 1.5B | 1.5B | 1.6B | 1.6B |
| Diluted average shares | 1.6B | 1.6B | 1.6B | 1.6B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 1.8B | 1.6B | 1.6B | 1.2B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |